BioInfra Life Science Inc. (XKON:266470)
South Korea · Delayed Price · Currency is KRW 104.00
+7.00 (7.22%)
At close: Apr 29, 2026
BioInfra Life Science Market Cap
BioInfra Life Science has a market cap or net worth of 2.25 billion as of April 29, 2026. Its market cap has decreased by -68.67% in one year.
Market Cap
2.25B
Enterprise Value
n/a
Revenue
1.78B
Ranking
n/a
PE Ratio
n/a
Stock Price
104.00
Market Cap Chart
Since July 22, 2020, BioInfra Life Science's market cap has decreased from 57.13B to 2.25B, a decrease of -96.06%. That is a compound annual growth rate of -42.90%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2026 | 2.10B | -64.73% |
| Dec 30, 2025 | 5.96B | -33.89% |
| Dec 30, 2024 | 9.01B | 75.26% |
| Dec 28, 2023 | 5.14B | -65.89% |
| Dec 29, 2022 | 15.08B | -60.07% |
| Dec 30, 2021 | 37.76B | -10.67% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Jul 22, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Celemics | 130.63B |
| Corentec | 75.05B |
| DENTIS CO.,Ltd | 62.92B |
| Finemedix | 38.66B |
| Genolution | 35.46B |
| TASCOM | 23.42B |
| Sanigen Co. | 14.02B |
| Alpha AI | 10.45B |